|
|
440 Creamery Way, Suite 300 Exton, PA 19341 USA phone:610 280 7300 fax:610 280 3779
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.absorption.com
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Preclinical and clinical drug development services for pharmaceutical and biotechnology clients. |
 |
| Management |
| Patrick M. Dentinger, President and CEO; Ismael J. Hidalgo, Ph.D., Chief Scientist; Albert Owen, Ph.D., Vice President, Scientific Operations; Sid Bhoopathy, Ph.D., Director of Operations; Patrick F. Carr, Jr., CPA, Chief Financial Officer; Chris Bode, Ph.D., Vice President, Corporate Development; Glenn Dobson, B.Sc., CLS, Manager, In Vivo-ADME Studies; Jibin Li, Ph.D., Director, Drug Metabolism and Pharmacokinetics; Vinko Rutar, Ph.D., Director of Quality; Tanja Obradovic, Ph.D., Director, Drug Transport Assays; Richard Jia, M.S., Senior Research Scientist |
| |
|
|
| |
|
| Keywords |
| ADME, physicochemical characterization, permeability, metabolism, pharmacokinetics, formulation optimization |
|
|
|
| Description |
|
Absorption Systems provides preclinical and clinical drug development services to pharmaceutical and biotechnology clients. Their portfolio of ADME services include physicochemical characterization, permeability and metabolism studies, pharmacokinetic studies in animals, and formulation optimization. |
 |
| Products / Services |
Absorption Systems specializes in three areas of drug discovery support: Rapid ADME/PK profiling of new chemical entities, Oral Drug Delivery System Characterization and Biopharmaceutical Classification System (BCS).
|
 |
| Technology / Differentiation |
| CellPort Technologies is a suite of novel, proprietary cell lines that provide in vitro data on P-gp interactions needed in NDA submissions. |
 |
| Market / Customers |
Pharmaceutical and biotechnology clients.
|
 |
|
|
|
|
|
|